Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Journal of Pharmacology and PharmacotherapeuticsNOW IN
    Article

    Drug Approval in India Does not Match the Disease Burden: A Cross‑sectional Study

    Jaykaran Charan1★, Jatin V. Dhanani2, Maulik Sumantbhai Doshi3, Tea Reljic4, Athanasios Tsalatsanis4, Ambuj Kumar4★ Corresponding author

    1. 1Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, Rajasthan.
    2. 2Department of Pharmacology, GMERS Medical College, Valsad, Gujarat.
    3. 3Department of Clinical Pharmacology, KEM Hospital, Mumbai, Maharashtra, India.
    4. 4USF Health Program for Comparative Effectiveness Research and Evidence Based Medicine, University of South Florida, Tampa, Florida, USA.

    CORRESPONDENCE

    Jaykaran Charan

    Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, Rajasthan.

    dr.jaykaran78@gmail.com

    Received: 19-12-2017; Revised: 03-02-2018; Accepted: 05-06-2018.

    Volume 9, Issue 1 · pp. 6–10 · PUBLISHED 2018 · DOI: 10.4103/jpp.JPP_168_17

    View on J Pharmacol. Pharmacother. original site ↗

    ABSTRACT

    Objectives: To assess the correlation between drug approval and disease burden in India. Materials and Methods: A cross sectional study was conducted and data on drug approval for the past 14 years (2000–2013) were downloaded from the central drug standard control organization website in India and the latest data on disease burden from the year 2012 were obtained the World Health Organization website. Mortality and disability (disease adjusted life year) were considered. Drug approval was correlated with disease burden using the Spearman’s correlation test. Results: Between 2000 and 2013, a total of 1913 drugs were approved in India. Of these, 838 were fixed‑dose combinations and 22 were veterinary drugs, which were excluded from the analysis. Due to a single‑drug being used for multiple indications, the final analysis was performed on 1345 indications/drugs. Overall, there was a weak correlation between disease burden and drug approval for the outcomes of mortality (r = 0.207, P = 0.038) and disability (r = 0.278, P = 0.002). Conclusion: The results from this first study assessing the correlation between drug approval and disease burden in India shows a significant mismatch and the urgent need for syncing the research output with the disease burden.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Charan, J., Dhanani, J. V., Doshi, M. S., Reljic, T., Tsalatsanis, A., & Kumar, A. (2018). Drug Approval in India Does not Match the Disease Burden: A Cross‑sectional Study. Journal of Pharmacology and Pharmacotherapeutics, 9(1), 6–10. https://doi.org/10.4103/jpp.JPP_168_17